Episiotomy Wound Healing. Pregnancy, childbirth and the puerperium
Conditions
Interventions
Intervention 1: Intervention group: 10 cc saline normal (9 in 1000 cc), manufactured by Samen Pharmaceutical Co., was sprinkled on episiotomy wound by a sterile syringe, three times a day for ten days
Treatment - Drugs
Intervention group: 10 cc saline normal (9 in 1000 cc), manufactured by Samen Pharmaceutical Co., was sprinkled on episiotomy wound by a sterile syringe, three times a day for ten days
Control group: 10 cc povidone iodine solution 10%, three tablespoons in four glasses of water, manufactured by Samen Pharmaceutical Co., was sprinkled on episiotomy wound by a sterile syringe, three t
Sponsors
Vice Chancellor for Research of Arak University Medical Sciences
Eligibility
Sex/Gender
Female
Age
15 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: full term pregnancy, singelton pregnancy with normal vaginal delivery, spontaneous placenta removal, PROM less than 18 hours, no illnesses that affect wound healing such as: cardiac, pulmonary, kidney disease, diabetes, anemia, coagolopathy and malnutrition Exclusion criteria: require to any antibiotics or immunosuppressive drugs during the study, change in location, not coming on the examination date and cases have not been instructed the plan of study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Episiotomy wound healing. Timepoint: The third, seventh and tenth days during treatment. Method of measurement: Rate of healing. | — |
Secondary
| Measure | Time frame |
|---|---|
| Edema, inflammation and redness. Timepoint: The third, seventh and tenth during treatment. Method of measurement: Reeda score. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahtab Attarha
Nursing and Midwifery Faculty of Arak University Medical Sciences
Outcome results
None listed